Prof Glenn Marshall
Professor Glenn Marshall is currently Director of the Kids Cancer Centre (KCC) at the Sydney Children's Hospital, Randwick (SCH), Head of the Molecular Carcinogenesis Program at the Children's Cancer Institute Australia, and conjoint Professor, School of Women and Children’s Health, Faculty of Medicine at UNSW. He has a major interest in the treatment of childhood leukaemia, neuroblastoma and bone tumours.
Professor Marshall has, for more than 20 years, researched the cause and therapy of childhood cancer diseases. He has published more than 100 original research articles on various biological and clinical aspects of child cancer and combines a busy clinical practice with supervising clinical, translational and basic research programs.
His longstanding research interests have been the clinical problems of detection and treatment of relapsed acute leukaemia in children, and the cause, prevention and treatment of embryonal child cancer.
He recently took on the role of Director for the new Translational Cancer Research Centre for Kids in NSW, known as the Kids Cancer Alliance, which is a network funded by Cancer Institute NSW bringing together several hundred pre-clinical and clinical researchers from across NSW.
His other research interest is improving learning and educational access for children being treated for chronic disease. With colleagues at the Children’s Hospital Westmead, John Hunter Children’s Hospital and Ronald McDonald Learning Program, in 2007 he helped initiate the Learning Pathways Project for Children with Cancer.
Professor Marshall graduated from the University of New South Wales in 1979 with a Bachelor of Medicine, Bachelor of Surgery (Hons). He then went on to do an internship and his first resident year at the St George Hospital, Kogarah, Sydney until 1981.
This was followed by paediatric training at the Prince of Wales Children's Hospital, now called Sydney Children’s Hospital, Randwick, from 1981 - 1987.
His background also includes a number of different professor positions at the Faculty of Medicine, University of New South Wales.
Professor Marshall has also completed a number of fellowships at the Division of Haematology/Oncology at Children's Hospital of Los Angeles, and, Department of Microbiology, University of Southern California School of Medicine, Los Angeles, California, USA between 1988-1991, a fellowship of the Royal Australasian College of Physicians in 1989 and a fellowship in Paediatric Haematology/Oncology at the Prince of Wales Children's Hospital, Sydney, 1987 - 1988.